| BSN Rank:
887 / 2941
(What's this?) |
|
Accomplish Score: 84
|
|
Popularity Score: Unavailable
|
|
# in My Circle: 0
|
|
# in My Org(s): 30744
|
| We'll Post Your CV for Free! |
| |
| |
|
Speaking/Presenting-Abstract/Poster at Mtg: 0 (0 / 0)
|
|
| |
|
Honors and Awards: 0 (0 / 0)
|
|
| |
|
Clinical Trial Activity: 0 (0 / 0)
|
|
| |
|
Grant Support: 0 (0 / 0)
|
|
| |
|
Patents Pending: 0 (0 / 0)
|
|
| |
|
Journal - Editor/Reviewer: 0 (0 / 0)
|
|
| |
|
Peer Reviewed Papers, Books, Chapters: 14 (84 / 0)
|
-
Worldwide, gastric cancer (GC) is one of the deadliest malignant tumors of the digestive system. ()
-
BACKGROUND:
Mucin 5AC (MUC5AC), as a member of secreted/gel-forming mucin family, was frequently found to be abnormally expressed in inflammation or malignant diseases. ()
-
During the proliferation and metastasis, the tumor cells prefer glycolysis (Warburg effect), but its exact mechanism remains largely unknown. ()
|
| |
|
Pre/Non Reviewed Papers, Proceedings: 0 (0 / 0)
|
|
| |
|
Membership in Professional Societies: 0 (0 / 0)
|
|
| |
|
White Papers: 0 (0 / 0)
|
|
| |
| Registered on BiotechScienceNews: 0 |
How We Rank
